Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy

Abstract Background Blood flow in the corpus luteum is associated with luteal function. However, the impact of luteal blood flow on methotrexate (MTX) treatment in women with unruptured tubal pregnancy has not been reported. The aim of the present study was to observe the impact of luteal blood flow...

Full description

Bibliographic Details
Main Authors: Li Wang, Meili Pei, Ting Yang, Juan Zhao, Xiaofeng Yang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12884-020-02882-3
id doaj-8ec1da5f7dc04d15acf5efc14803637c
record_format Article
spelling doaj-8ec1da5f7dc04d15acf5efc14803637c2020-11-25T02:38:06ZengBMCBMC Pregnancy and Childbirth1471-23932020-03-012011810.1186/s12884-020-02882-3Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancyLi Wang0Meili Pei1Ting Yang2Juan Zhao3Xiaofeng Yang4Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong UniversityAbstract Background Blood flow in the corpus luteum is associated with luteal function. However, the impact of luteal blood flow on methotrexate (MTX) treatment in women with unruptured tubal pregnancy has not been reported. The aim of the present study was to observe the impact of luteal blood flow on the therapeutic effect of MTX in women with unruptured tubal pregnancy. Methods A prospective observational study recruited 129 women with unruptured tubal pregnancy in the First Affiliated Hospital of Xi’an Jiaotong University from September 2016 to June 2018. One hundred and fifteen women were treated successfully with MTX, and women were divided into 2 groups according to luteal blood flow: the poor luteal blood flow group and the abundant luteal blood flow group. The therapeutic effects were compared between the two groups. Results Women in the abundant luteal blood flow group had a significantly higher serum β-human chorionic gonadotropin (β-hCG) level 4 days, 1 week and 2 weeks after MTX treatment compared with women in the poor luteal blood flow group (P < 0.05). The average diameter of the ectopic mass 1 week, 2 weeks and 3 weeks after MTX treatment in women with abundant luteal blood flow was significantly larger (P < 0.05), and the time of serum β-hCG clearance and ectopic mass disappearance were significantly longer compared with those in women in the poor luteal blood flow group (P < 0.05). Conclusions Luteal blood flow might be a predictive factor for MTX treatment outcomes in women with unruptured tubal pregnancy, and those with abundant luteal blood flow need a longer recovery time.http://link.springer.com/article/10.1186/s12884-020-02882-3Luteal blood flowMethotrexateUnruptured tubal pregnancyPredictive factor
collection DOAJ
language English
format Article
sources DOAJ
author Li Wang
Meili Pei
Ting Yang
Juan Zhao
Xiaofeng Yang
spellingShingle Li Wang
Meili Pei
Ting Yang
Juan Zhao
Xiaofeng Yang
Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
BMC Pregnancy and Childbirth
Luteal blood flow
Methotrexate
Unruptured tubal pregnancy
Predictive factor
author_facet Li Wang
Meili Pei
Ting Yang
Juan Zhao
Xiaofeng Yang
author_sort Li Wang
title Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
title_short Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
title_full Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
title_fullStr Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
title_full_unstemmed Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
title_sort luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy
publisher BMC
series BMC Pregnancy and Childbirth
issn 1471-2393
publishDate 2020-03-01
description Abstract Background Blood flow in the corpus luteum is associated with luteal function. However, the impact of luteal blood flow on methotrexate (MTX) treatment in women with unruptured tubal pregnancy has not been reported. The aim of the present study was to observe the impact of luteal blood flow on the therapeutic effect of MTX in women with unruptured tubal pregnancy. Methods A prospective observational study recruited 129 women with unruptured tubal pregnancy in the First Affiliated Hospital of Xi’an Jiaotong University from September 2016 to June 2018. One hundred and fifteen women were treated successfully with MTX, and women were divided into 2 groups according to luteal blood flow: the poor luteal blood flow group and the abundant luteal blood flow group. The therapeutic effects were compared between the two groups. Results Women in the abundant luteal blood flow group had a significantly higher serum β-human chorionic gonadotropin (β-hCG) level 4 days, 1 week and 2 weeks after MTX treatment compared with women in the poor luteal blood flow group (P < 0.05). The average diameter of the ectopic mass 1 week, 2 weeks and 3 weeks after MTX treatment in women with abundant luteal blood flow was significantly larger (P < 0.05), and the time of serum β-hCG clearance and ectopic mass disappearance were significantly longer compared with those in women in the poor luteal blood flow group (P < 0.05). Conclusions Luteal blood flow might be a predictive factor for MTX treatment outcomes in women with unruptured tubal pregnancy, and those with abundant luteal blood flow need a longer recovery time.
topic Luteal blood flow
Methotrexate
Unruptured tubal pregnancy
Predictive factor
url http://link.springer.com/article/10.1186/s12884-020-02882-3
work_keys_str_mv AT liwang lutealbloodflowasapredictivefactorformethotrexatetreatmentoutcomesinwomenwithunrupturedtubalpregnancy
AT meilipei lutealbloodflowasapredictivefactorformethotrexatetreatmentoutcomesinwomenwithunrupturedtubalpregnancy
AT tingyang lutealbloodflowasapredictivefactorformethotrexatetreatmentoutcomesinwomenwithunrupturedtubalpregnancy
AT juanzhao lutealbloodflowasapredictivefactorformethotrexatetreatmentoutcomesinwomenwithunrupturedtubalpregnancy
AT xiaofengyang lutealbloodflowasapredictivefactorformethotrexatetreatmentoutcomesinwomenwithunrupturedtubalpregnancy
_version_ 1724792778449223680